Other

Dataset Information

0

Withanolide analogues disrupt a leukemic dependency on cholesterol transport by inhibiting the oxysterol-binding protein OSBP  [CRISPR screen]


ABSTRACT: Metabolic alterations in cancers precipitate in associated dependencies that can be therapeutically exploited. To meet this goal, natural product inspired small molecules can provide a resource of underexplored chemotypes. Here, we identify W7, a synthetic withanolide analog with pronounced anti-leukemic properties via orthogonal chemical screening. Through multi-omics profiling and genome-scale CRISPR/Cas9 screens, we identify that W7 disrupts Golgi homeostasis via a mechanism that requires active PI4P signaling at the ER-Golgi membrane interface. Thermal proteome profiling and genetic validation studies reveal the oxysterol-binding protein OSBP as the direct and phenotypically relevant target of W7. Collectively, these data reaffirm sterol transport as a therapeutically actionable dependency in leukemia and motivate ensuing translational investigation via the probe-like compound W7.

ORGANISM(S): Homo sapiens

PROVIDER: GSE226848 | GEO | 2023/03/15

REPOSITORIES: GEO

Similar Datasets

2023-03-15 | GSE226847 | GEO
2023-03-15 | GSE226849 | GEO
2023-09-24 | GSE240960 | GEO
2024-02-16 | GSE255970 | GEO
2024-02-16 | GSE255894 | GEO
2023-11-20 | PXD046322 | Pride
2023-03-20 | GSE227667 | GEO
2022-11-17 | PXD035302 | Pride
2023-10-12 | MSV000093086 | MassIVE
2023-04-17 | MSV000091726 | MassIVE